Korean J Clin Microbiol.  2010 Mar;13(1):27-33. 10.5145/KJCM.2010.13.1.27.

Carbapenem Resistance Mechanisms and Molecular Epidemiology of Acinetobacter spp. from Four Hospitals in Seoul and Gyeonggi Province in 2006

Affiliations
  • 1Department of Laboratory Medicine, Korea University College of Medicine, Korea.
  • 2Korean Institute of Tuberculosis, Seoul, Korea.
  • 3Department of Clinical Laboratory Science, Dongeui University, Busan, Korea.
  • 4Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. leekcp@yuhs.ac
  • 5Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Increasing numbers of Acinetobacter spp. resistant to multiple drugs, including carbapenem, has been a serious problem. The aims of this study were to determine carbapenem resistance patterns and mechanisms, as well as to study the molecular epidemiology of Acinetobacter spp.
METHODS
Clinical isolates of Acinetobacter spp. were collected from May to November in 2006. Antimicrobial susceptibility testing was performed using CLSI disk diffusion and agar dilution methods. Metallo-beta-lactamase- and OXA carbapenemase-producing isolates were detected by PCR. Carbapenem resistance and hydrolytic activities were compared according to OXA type and presence of ISAba1. Pulsed-field gel electrophoresis (PFGE) was performed to determine the epidemiologic features.
RESULTS
The imipenem non-susceptible rates were variable from 10% to 67%. Among 151 isolates carrying bla(OXA-51-like), 75 isolates carried both bla(OXA-51-like) and ISAba1, and 25 isolates had both bla(OXA-51-like), bla(OXA-23-like), and ISAba1. Carbapenem MICs of both bla(OXA-51-like) and ISAba1-carrying isolates were higher than those with bla(OXA-51-like) only. Carbapenem MICs of bla(OXA-23-like)-carrying isolates were higher than those with both bla(OXA-51-like) and ISAba1. Both bla(OXA-51-like) and ISAba1-carrying isolates and blaOXA-51-like, blaOXA-23-like, and ISAba1-carrying isolates demonstrated higher hydrolysis activities in oxacillin and carbapenems. Most of the tested isolates were susceptible to tigecycline, and all of them were susceptible to colistin. Pulsed-field gel electrophoresis suggested that there had been several outbreaks of bla(OXA-23-like) and bla(OXA-51-like)-positive strains.
CONCLUSION
Carbapenem non-susceptible Acinetobacter isolates and OXA carbapenemase-producing isolates were prevalent. Dissemination of bla(OXA)-harboring isolates may make it difficult to treat infections due to carbapenem-resistant Acinetobacter spp. Further surveillance studies are required to prevent the spread of carbapenem resistance.

Keyword

OXA carbapenemase; Carbapenem; Acinetobacter; Outbreak

MeSH Terms

Acinetobacter
Agar
Carbapenems
Colistin
Diffusion
Disease Outbreaks
Electrophoresis, Gel, Pulsed-Field
Hydrolysis
Imipenem
Lifting
Minocycline
Molecular Epidemiology
Oxacillin
Oxytocin
Polymerase Chain Reaction
Agar
Carbapenems
Colistin
Imipenem
Minocycline
Oxacillin
Oxytocin

Figure

  • Fig. 1. Pulsed-field gel electrophoresis (PFGE) patterns of SmaI-restricted genomic DNA of Acinetobacter spp. isolates. (A) Isolates having blaOXA-51 and ISAbaI. Lane I to IX, different clones from 4 hospitals; and (B) isolates having both blaOXA-51, blaOXA-23 and ISAbaI. Lane I-1 to IV, different clones from 4 hospitals; Molecular size (ladder marker) is given in kilobases.


Cited by  1 articles

Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
Kyungwon Lee, Dongeun Yong, Seok Hoon Jeong, Yunsop Chong
Yonsei Med J. 2011;52(6):879-891.    doi: 10.3349/ymj.2011.52.6.879.


Reference

1. Bergogne-Bérézin E and Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9:148–65.
Article
2. Lee K, Lim CH, Cho JH, Lee WG, Uh Y, Kim HJ, et al. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med J. 2006; 47:634–45.
Article
3. Lee K, Jang SJ, Lee HJ, Ryoo N, Kim M, Hong SG, et al. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci. 2004; 19:8–14.
4. Poirel L and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12:826–36.
5. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39:1211–33.
6. Walther-Rasmussen J and H⊘oiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006; 57:373–83.
7. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol. 2005; 43:4826–9.
8. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol. 2005; 43:2241–5.
9. Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother. 2005; 55:115–8.
10. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006; 258:72–7.
Article
11. Lee K, Kim MN, Choi TY, Cho SE, Lee S, Whang DH, et al. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents. 2009; 33:520–4.
Article
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth ed. Wayne, PA: CLSI;2006.
13. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7:88–91.
14. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005; 49:4485–91.
15. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006; 27:351–3.
Article
16. Merkier AK and Centróon D. blaOXA-51-type β-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents. 2006; 28:110–3.
17. Tsakris A, Ikonomidis A, Pournaras S, Spanakis N, Markogiannakis A. Carriage of OXA-58 but not of OXA-51 β-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2006; 58:1097–9.
Article
18. Segal H, Garny S, Elisha BG. Is ISAba-1 customized for Acinetobacter ? FEMS Microbiol Lett. 2005; 243:425–9.
Full Text Links
  • KJCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr